Scott Thomas Jackson serves as Executive at Celator Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Scott Thomas Jackson has executed 13 insider transactions totaling $57.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 29, 2024 involved receiving (via award) 20,000 shares valued at $0.
Scott Thomas Jackson currently holds 55,000 shares of Celator Pharmaceuticals Inc (CPXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Thomas Jackson has been a net buyer of CPXX stock. They have purchased $57.6K and sold $0 worth of shares.
Scott Thomas Jackson's most recent insider trade was on May 29, 2024, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 5, 2023 | SPRO | $0 | Award | 20,000 | $N/A | Discretionary |
| Sep 15, 2022 | SPRO | $0 | Award | 15,000 | $N/A | Discretionary |
| May 18, 2021 | GLYC | $0 | Award | 5,250 | $N/A | Discretionary |
| Jul 12, 2016 | CPXX | $9.1M | Disposition | 301,518 | $30.25 | Discretionary |
| Jul 7, 2016 | CPXX | $300.4K | Option Exercise | 96,276 | $3.12 | Discretionary |
| Jul 7, 2016 | CPXX | $128.5K | Option Exercise | 38,135 | $3.37 | Discretionary |
| Jul 7, 2016 | CPXX | $285.6K | Option Exercise | 117,064 | $2.44 | Discretionary |
| Oct 6, 2015 | CPXX | $25.1K | Purchase | 14,450 | $1.74 | Discretionary |
| Feb 25, 2015 | CPXX | $0 | Award | 22,593 | $N/A | Discretionary |
| Nov 18, 2014 | CPXX | $22.0K | Purchase | 10,000 | $2.20 | Discretionary |
| Dec 17, 2013 | CPXX | $10.5K | Purchase | 3,000 | $3.50 | Discretionary |